Infant Bacterial Therapeutics AB approved FDA Type B Pre-BLA meeting
FDA approved a Type B Pre-BLA meeting for IBP-9414 on Oct. 29, 2026 in Washington.
Story updates
07:08:59 AM UTC
SquawkNews
Infant Bacterial Therapeutics AB OMXSTO:IBT_B
Infant Bacterial Therapeutics AB received FDA approval for a Type B Pre-BLA meeting on IBP-9414, scheduled for Oct. 29, 2026, in Washington.